Colgate-Palmolive (NYSE:CL) CFO Dennis J. Hickey sold 5,651 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $70.18, for a total transaction of $396,587.18. Following the transaction, the chief financial officer now directly owns 413,221 shares in the company, valued at approximately $28,999,849.78. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Colgate-Palmolive (NYSE CL) traded up $0.91 during mid-day trading on Friday, reaching $70.30. 2,325,207 shares of the company were exchanged, compared to its average volume of 4,217,950. The firm has a market cap of $61,050.00, a PE ratio of 26.98, a PEG ratio of 2.56 and a beta of 0.75. The company has a quick ratio of 1.00, a current ratio of 1.36 and a debt-to-equity ratio of 27.02. Colgate-Palmolive has a one year low of $68.19 and a one year high of $77.91.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 26th. The company reported $0.75 EPS for the quarter, meeting the consensus estimate of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same period in the previous year, the business posted $0.75 EPS. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. sell-side analysts anticipate that Colgate-Palmolive will post 3.18 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.28%. The ex-dividend date of this dividend was Monday, January 22nd. Colgate-Palmolive’s payout ratio is 61.78%.
A number of research analysts have commented on CL shares. Deutsche Bank started coverage on shares of Colgate-Palmolive in a research report on Wednesday, December 13th. They set a “hold” rating and a $75.00 target price on the stock. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Monday, January 15th. Macquarie raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price on the stock in a research report on Tuesday, December 19th. Stifel Nicolaus set a $73.00 target price on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Sunday, October 29th. Finally, Societe Generale downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price on the stock. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and five have issued a buy rating to the stock. Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $77.91.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Blue Chip Partners Inc. lifted its stake in shares of Colgate-Palmolive by 0.4% in the 2nd quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock valued at $134,000 after purchasing an additional 8 shares during the period. AlphaMark Advisors LLC lifted its stake in shares of Colgate-Palmolive by 1.5% in the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after purchasing an additional 25 shares during the period. Weatherstone Capital Management lifted its stake in shares of Colgate-Palmolive by 0.7% in the 2nd quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock valued at $302,000 after purchasing an additional 28 shares during the period. Dorsey & Whitney Trust CO LLC increased its holdings in Colgate-Palmolive by 0.6% in the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 5,642 shares of the company’s stock worth $419,000 after acquiring an additional 34 shares in the last quarter. Finally, Jackson Grant Investment Advisers Inc. increased its holdings in Colgate-Palmolive by 0.5% in the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 7,028 shares of the company’s stock worth $521,000 after acquiring an additional 35 shares in the last quarter. Institutional investors and hedge funds own 71.52% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Colgate-Palmolive (CL) CFO Dennis J. Hickey Sells 5,651 Shares” was first published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://www.thelincolnianonline.com/2018/02/23/colgate-palmolive-cl-cfo-dennis-j-hickey-sells-5651-shares.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.